Serin Formulations Private Limited, a active private limited company, was established on 21 December 2001 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24231TG2001PTC038249. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 30 professional, Its leadership includes Vannem Reddy Satti Raju (Director), Kodali Uma Shankar (Whole-Time Director), Vejju Venkateswara Rao (Managing Director). Past directors included Venkata Ramakishan Vummethala. It holds ₹6.50 M open charges and ₹1.01 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12-6-23/6/4/2,Sai Shakthi Bhavan Shivasakthi Nagar,Moosapet, Hyderabad, Telangana, 500018.
U24231TG2001PTC038249
038249
21 December 2001
₹5.00 M
₹5.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Serin Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vannem Reddy Satti Raju | Director | 21 Dec 2001 | Current |
| Kodali Uma Shankar | Whole-Time Director | 21 Dec 2001 | Current |
| Vejju Venkateswara Rao | Managing Director | 21 Dec 2001 | Current |
| Naga Satyavathi Pasam | Director | 21 Dec 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 30 Jun 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serin Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 5.09% increase in profit. The company's net worth Soared by an impressive increase of 16.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Serin Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹10,068,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2022 | Bank Of India | ₹6.50 M | Open |
| 29 May 2019 | Hdfc Bank Limited | ₹7.57 M | Satisfied |
| 23 May 2002 | Bank Of India | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Serin Formulations has a workforce of 30 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Serin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serin Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Serin Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Serin Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge registered on 29 May 2019 via Charge ID 100268710 with Hdfc Bank Limited was fully satisfied on 17 May 2022. was documented.
The activity A charge with Bank Of India amounted to Rs. 6.50 M with Charge ID 100583036 was registered on 27 Feb 2022. was completed.
The activity A charge with Hdfc Bank Limited of Rs. 7.57 M registered on 29 May 2019 with Charge ID 100268710 was modified on 23 Jun 2020. was completed.
A charge registered on 23 May 2002 via Charge ID 90133010 with Bank Of India was fully satisfied on 15 Jun 2019. was recorded as a recent event.
The CIN of Serin Formulations Private Limited is U24231TG2001PTC038249.
Serin Formulations Private Limited is headquartered at 12-6-23/6/4/2,Sai Shakthi Bhavan Shivasakthi Nagar,Moosapet, Hyderabad, Telangana, 500018.
Serin Formulations Private Limited was incorporated on 21 December 2001.
The current directors of Serin Formulations Private Limited are
The primary industry of Serin Formulations Private Limited is Manufacturing.
Serin Formulations Private Limited is unlisted.
The authorized capital of Serin Formulations Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Serin Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX